IDENTIFICATION OF NUCLEOLIN AS A BINDING-PROTEIN FOR MIDKINE (MK) AND HEPARIN-BINDING GROWTH-ASSOCIATED MOLECULE (HB-GAM)

被引:104
作者
TAKE, M
TSUTSUI, J
OBAMA, H
OZAWA, M
NAKAYAMA, T
MARUYAMA, I
ARIMA, T
MURAMATSU, T
机构
[1] KAGOSHIMA UNIV,FAC MED,DEPT BIOCHEM,KAGOSHIMA 890,JAPAN
[2] KAGOSHIMA UNIV,FAC MED,DEPT LAB MED,KAGOSHIMA 890,JAPAN
[3] MIYAZAKI MED COLL,DEPT BIOCHEM,MIYAZAKI 88916,JAPAN
[4] NAGOYA UNIV,SCH MED,DEPT BIOCHEM,SHOWA KU,NAGOYA,AICHI 466,JAPAN
关键词
FIBROBLAST GROWTH FACTOR; HEPARIN-BINDING GROWTH ASSOCIATED MOLECULE; MIDKINE; NUCLEAR TRANSLOCATION; NUCLEOLIN;
D O I
10.1093/oxfordjournals.jbchem.a124628
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Midkine (MK) is a heparin-binding growth/differentiation factor with a molecular weight of 13 kDa, and is structurally unrelated to fibroblast growth factors (FGF). We studied MK-binding proteins in order to clarify the action mechanism of MK. A 100-kDa protein was identified in PYS-2, 3T3, and L cells as an MK-binding protein by a ligand blot experiment. This MK-binding protein was purified by affinity chromatography on an MK-agarose column followed by SDS polyacrylamide gel electrophoresis. Sequence determination of N-terminal 23 amino acid residues revealed that the MK-binding protein was nucleolin, a major nucleolar protein, which functions as a shuttle protein between the nucleus and cytoplasm and is located also on the cell surface. Heparin-binding growth associated molecule (HB-GAM), which has 50% sequence identity with MK, fused to maltose-binding protein also bound to nucleolin. On the other hand, basic FGF (bFGF) scarcely bound to nucleolin in the absence of heparin, while both MK and bFGF bound weakly to nucleolin in the presence of heparin. Nuclear localization of MK was shown in hemangioma cells by immunohistochemical staining. These findings supported the hypothesis that parts of the MK and HB-GAM are translocated to the nucleus after binding with nucleolin.
引用
收藏
页码:1063 / 1068
页数:6
相关论文
共 41 条
[1]   TRANSLOCATION OF BFGF TO THE NUCLEUS IS G1 PHASE CELL-CYCLE SPECIFIC IN BOVINE AORTIC ENDOTHELIAL-CELLS [J].
BALDIN, V ;
ROMAN, AM ;
BOSCBIERNE, I ;
AMALRIC, F ;
BOUCHE, G .
EMBO JOURNAL, 1990, 9 (05) :1511-1517
[2]   MAJOR NUCLEOLAR PROTEINS SHUTTLE BETWEEN NUCLEUS AND CYTOPLASM [J].
BORER, RA ;
LEHNER, CF ;
EPPENBERGER, HM ;
NIGG, EA .
CELL, 1989, 56 (03) :379-390
[3]   BASIC FIBROBLAST GROWTH-FACTOR ENTERS THE NUCLEOLUS AND STIMULATES THE TRANSCRIPTION OF RIBOSOMAL GENES IN ABAE CELLS UNDERGOING G0-]G1 TRANSITION [J].
BOUCHE, G ;
GAS, N ;
PRATS, H ;
BALDIN, V ;
TAUBER, JP ;
TEISSIE, J ;
AMALRIC, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) :6770-6774
[4]  
BOUCHE G, 1984, NUCLEIC ACIDS RES, V12, P3025, DOI 10.1093/nar/12.7.3025
[5]   ROLE OF PHOSPHORYLATION ON THE MATURATION PATHWAYS OF A 100 KDA NUCLEOLAR PROTEIN [J].
BOURBON, H ;
BUGLER, B ;
CAIZERGUESFERRER, M ;
AMALRIC, F .
FEBS LETTERS, 1983, 155 (02) :218-222
[6]   STRUCTURE OF THE MOUSE NUCLEOLIN GENE - THE COMPLETE SEQUENCE REVEALS THAT EACH RNA-BINDING DOMAIN IS ENCODED BY 2 INDEPENDENT EXONS [J].
BOURBON, HM ;
LAPEYRE, B ;
AMALRIC, F .
JOURNAL OF MOLECULAR BIOLOGY, 1988, 200 (04) :627-638
[7]   ALTERNATIVE INITIATION OF TRANSLATION DETERMINES CYTOPLASMIC OR NUCLEAR-LOCALIZATION OF BASIC FIBROBLAST GROWTH-FACTOR [J].
BUGLER, B ;
AMALRIC, F ;
PRATS, H .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) :573-577
[8]   PHOSPHORYLATION OF NUCLEOLIN BY A NUCLEOLAR TYPE-NII PROTEIN-KINASE [J].
CAIZERGUESFERRER, M ;
BELENGUER, P ;
LAPEYRE, B ;
AMALRIC, F ;
WALLACE, MO ;
OLSON, MOJ .
BIOCHEMISTRY, 1987, 26 (24) :7876-7883
[9]   KARYOPHILIC PEPTIDES - APPLICATIONS TO THE STUDY OF NUCLEAR TRANSPORT [J].
GOLDFARB, DS .
CELL BIOLOGY INTERNATIONAL REPORTS, 1988, 12 (09) :809-832
[10]   A RETINOIC ACID RESPONSIVE GENE MK FOUND IN THE TERATOCARCINOMA SYSTEM IS EXPRESSED IN SPATIALLY AND TEMPORALLY CONTROLLED MANNER DURING MOUSE EMBRYOGENESIS [J].
KADOMATSU, K ;
HUANG, RP ;
SUGANUMA, T ;
MURATA, F ;
MURAMATSU, T .
JOURNAL OF CELL BIOLOGY, 1990, 110 (03) :607-616